Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
351-02-015 / 351-02-015 ISMRM Abstract

Lumbar MRI Radiomics for Non-invasive ISS/R-ISS Stratification in Newly Diagnosed Multiple Myeloma: A Two-Center Study

Primary: Musculoskeletal - Other Musculoskeletal
Secondary: Musculoskeletal - Whole Joint
351-02-015 · MSK: Everything, Everywhere, and All at Once · Monday, 11 May, 1:50 PM–3:26 PM · Power Pitch Theatre 1
351-02-015 · MSK: Everything, Everywhere, and All at Once · Monday, 11 May, 1:50 PM–3:26 PM · Power Pitch Theatre 1
Keywords: Radiomics Risk Stratification Multiple myeloma Spine
Accepted
Hao Wenhan 1, Fei Zheng2, Xinyi Gou2, Ping Yin2, Sicong Wang3, Zhang Chuanchen4, Hong Nan2
1Department of Radiology, Peking University People's Hospital, Beijing, China
2Department of Radiology, Peking University People's Hospital, Beijing, China
3MRI Research, GE Healthcare, Beijing, China
4Liaocheng People's Hsopital, Liaocheng,Shandong,China, China
Presenting Author: Hao Wenhan

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Niels W C J Van De Donk CPKL. Multiple myeloma. Lancet 2021;397:410-27. doi: 10.1016/S0140-6736(21)00135-5 [doi]
2. Palumbo A, Avet-Loiseau H, Oliva S, et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 2015;33:2863-9. doi: 10.1200/JCO.2015.61.2267 [doi]
3. Dimopoulos MA, Jakubowiak AJ, McCarthy PL, et al. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J 2020;10:17. doi: 10.1038/s41408-020-0273-x [doi]
4. Balmaceda N, Aziz M, Chandrasekar VT, et al. Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019. BMC Cancer 2021;21:730. doi:10.1186/s12885-021-08451-x [doi]
5. Liu J, Guo W, Zeng P, et al. Vertebral mri-based radiomics model to differentiate multiple myeloma from metastases: influence of features number on logistic regression model performance. Eur Radiol 2022;32:572-81. doi:10.1007/s00330-021-08150-y [doi]
6. Kim DK, Jung J, Kim H, et al. Development of a semiquantitative whole-body mri scoring system for multiple myeloma. Radiology 2023;308:e230667. doi:10.1148/radiol.230667 [doi]
7. Yan Y, Wang H, Huang Y, et al. Cross-modal vertical federated learning for mri reconstruction. IEEE J Biomed Health Inform 2024;28:6384-94. doi:10.1109/JBHI.2024.3360720 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/351-02-015